9.8% Above Target

Wall Street's consensus price target for CPSH is $6, -9.8% from its current price of $6.65. The below-market target from 0 analysts suggests limited near-term appreciation.

CPSH has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $6 implies -9.8% downside from current levels.

At a forward P/E of 166.25x, CPSH trades at a premium valuation. The consensus price target of $6 (-9.8% downside) suggests analysts may view current valuations as stretched.

The most bullish Wall Street analyst has a price target of $6 for CPSH, while the most conservative target is $6. The consensus of $6 represents the median expectation. Our quantitative valuation model projects a bull case target of $3 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

CPSH is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month CPSH stock forecast based on 0 Wall Street analysts shows a consensus price target of $6, with estimates ranging from $6 (bear case) to $6 (bull case). The median consensus rating is "N/A". Our proprietary valuation model produces a base case fair value of $2, with bear/bull scenarios of $1/$3.

Our quantitative valuation model calculates CPSH's fair value at $2 (base case), with a bear case of $1 and bull case of $3. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 38/100.

CPSH trades at a forward P/E ratio of 166.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 243.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on CPSH, with 0 Sell ratings and a price target of $6 (-9.8% from current price). The "N/A" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

CPSH analyst price targets range from $6 to $6, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $6 consensus represents the middle ground. Our model's $1-$3 range provides an independent fundamental perspective.